Polyphron
AI-guided tissue foundry for artificial human biology
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Polyphron is a New York biotech building an autonomous tissue foundry that manufactures and simulates donor-diverse human tissues. Its platform combines physical tissue production from stem cells with a simulation layer intended to help test therapeutic hypotheses against living human biology. The company publicly describes products including a Tissue Foundry and Tissue World Model, and announced a $20M seed round led by Quiet Capital (with Gradient, Haystack, and Compound) in September 2026. Founders include CEO Matthew Osman, CSO Fabio Boniolo, and Chief AI Scientist Vinh Q. Tran.
- Website
- polyphron.com
- Stage
- seed
- Location
- New York, NY, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Tissue Foundry — Automated physical system that grows human micro-tissue from stem cells